C
Chun Liang Lei
Researcher at Guangzhou Medical University
Publications - 3
Citations - 2888
Chun Liang Lei is an academic researcher from Guangzhou Medical University. The author has contributed to research in topics: Hazard ratio & Interquartile range. The author has an hindex of 3, co-authored 3 publications receiving 2257 citations.
Papers
More filters
Journal ArticleDOI
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
Wei Jie Guan,Wenhua Liang,Yi Zhao,Heng Rui Liang,Zi Sheng Chen,Yimin Li,Xiaoqing Liu,Ru Chong Chen,Chun Li Tang,Tao Wang,Chun-Quan Ou,Li Li,Ping Yan Chen,Ling Sang,Wei Wang,Jianfu Li,Caichen Li,Li Min Ou,Bo Cheng,Shan Xiong,Zheng Yi Ni,Jie Xiang,Yu Hu,Lei Liu,Hong Shan,Chun Liang Lei,Yi Xiang Peng,Li Wei,Yong Liu,Ya Hua Hu,Peng Peng,Jian-ming Wang,Ji Yang Liu,Zhong Chen,Gang Li,Zhi Jian Zheng,Shao Qin Qiu,Jie Luo,Chang Jiang Ye,Shao Yong Zhu,Lin Ling Cheng,Feng Ye,Shi Yue Li,Jin Ping Zheng,Nuo Fu Zhang,Nanshan Zhong,Jianxing He +46 more
TL;DR: It is found that among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without and a greater number ofComorbidities also correlated with poorer clinical outcome.
Journal ArticleDOI
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
Wenhua Liang,Wei Jie Guan,Caichen Li,Yimin Li,Heng Rui Liang,Yi Zhao,Xiaoqing Liu,Ling Sang,Ling Sang,Ru Chong Chen,Chun Li Tang,Tao Wang,Wei Wang,Qi Hua He,Zi Sheng Chen,Sook San Wong,Mark Zanin,Jun Liu,Xin Xu,Jun Huang,Jianfu Li,Li Min Ou,Bo Cheng,Shan Xiong,Zhan Hong Xie,Zheng Yi Ni,Yu Hu,Lei Liu,Hong Shan,Chun Liang Lei,Yi Xiang Peng,Li Wei,Yong Liu,Ya Hua Hu,Peng Peng,Jian-ming Wang,Ji Yang Liu,Zhong Chen,Gang Li,Zhi Jian Zheng,Shao Qin Qiu,Jie Luo,Chang Jiang Ye,Shao Yong Zhu,Lin Ling Cheng,Feng Ye,Shi Yue Li,Jin Ping Zheng,Nuo Fu Zhang,Nuo Fu Zhang,Nanshan Zhong,Jianxing He +51 more
TL;DR: There were more severe cases and poorer outcomes for COVID-19 patients treated in Hubei, which might be attributed to the prolonged duration of symptom onset to hospitalisation in the epicentre, and the reason for delaying hospitalisation is warranted.
Journal ArticleDOI
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia: A Randomized Clinical Trial.
Lin Ling Cheng,Wei Jie Guan,Chong Yang Duan,Nuo Fu Zhang,Chun Liang Lei,Yu Hu,Ai Lan Chen,Shi Yue Li,Chao Zhuo,Xi Long Deng,Fan Jun Cheng,Yong Gao,Jian Heng Zhang,Jia Xing Xie,Hong Peng,Ying Xian Li,Xiao Xiong Wu,Wen Liu,Hui Peng,Jian Wang,Guang Ming Xiao,Ping Yan Chen,Chunyan Wang,Zi Feng Yang,Jin Cun Zhao,Nanshan Zhong +25 more
TL;DR: In preliminary findings from a randomized clinical trial, rhG-CSF treatment for patients with COVID-19 with lymphopenia but no comorbidities did not accelerate clinical improvement, but the number of patients developing critical illness or dying may have been reduced.